General
Each Reporting Person acquired the shares of the Common Stock reported in this Schedule 13D for investment purposes and intends to review such investment in the Issuer on a continuing basis. As a member of the Board, as Chief Executive Officer or as a stockholder of the Issuer, Mr. Rowan may engage in communications with, without limitation, one or more stockholders of the Issuer, management of the Issuer and/or one or more members of the Board and may make suggestions concerning the Issuer’s operations, prospects, business and financial strategies, strategic transactions, assets and liabilities, business and financing alternatives, the composition of the Board and such other matters as Mr. Rowan may deem relevant to his or the other Reporting Person’s investment in, and position with, the Issuer. Each Reporting Person expects that he or it will, from time to time, review his or its investment position in the shares of the Common Stock or the Issuer and may, depending on the Issuer’s performance and other market conditions, increase or decrease his or its investment position in the Common Stock. A Reporting Person may, from time to time, make additional purchases of shares of the Common Stock either in the open market or in privately negotiated transactions, depending upon his or its evaluation of the Issuer’s business, prospects, financial condition or results of operations, the market for the Common Stock, other opportunities available to the Reporting Person, general economic conditions, stock market conditions or other factors. Depending upon the factors noted above, any Reporting Person may also decide to hold or dispose of all or part of his or its investments in the Common Stock, including, but not limited to, through a donation to a donor-advised fund or other charity. Any action such Reporting Person might undertake may be made at any time and from time to time without prior notice and will be dependent upon such Reporting Person’s review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer’s business, financial condition, operations and prospects; price levels of the Issuer’s securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments.
Except as set forth in this Item 4 or Item 6 below, no Reporting Person has any present plans or proposals that relate to, or that would result in, any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D under the Securities Exchange Act of 1934, as amended. The information in Items 3 and 6 is incorporated herein by reference.
Item 5. | Interest in Securities of the Issuer. |
(a) and (b) Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.
Such information is based on 570,921,096 shares of Common Stock, par value $0.00001 per share, of the Issuer outstanding as of January 6, 2022, as provided to the Reporting Person by the Issuer.
Marc Rowan may be deemed to beneficially own, and have sole voting and dispositive power over, the shares of Common Stock held by MJR Foundation and AOG Holdings due to his position as the Managing Member of MJR Foundation and as the indirect owner of the Managing Member of AOG Holdings. As of the date hereof, Mr. Rowan would be deemed to be the beneficial owner with sole voting and dispositive power of 35,082,816 shares of Common Stock in the aggregate, which represents approximately 6.1% of the outstanding Common Stock.
MJR Foundation holds and beneficially owns 26,782,555 shares of Common Stock, which represents approximately 4.7% of the outstanding Common Stock, and has sole voting and dispositive power over such shares of Common Stock it holds.
AOG Holdings beneficially owns 6,481,402 shares of Common Stock, which represents approximately 1.1% of the outstanding Common Stock, and has sole voting and dispositive power over such shares of Common Stock.
Series A Holdings beneficially owns the 6,481,402 shares of Common Stock held by AOG Holdings, which represents approximately 1.1% of the outstanding Common Stock, and has sole voting and dispositive power over such shares of Common Stock.